12,372 trials
Diabetes Mellitus, Type 2
Primary: The Change From Baseline in HbA1c After 24 Weeks of Treatment in Main Group — -1.29; -1.64; -2.07; -2.15 percentage — p=0.0587
Acute Respiratory Distress Syndrome
Primary: Mean PaO2/FiO2 Ratio — 115.6; 115.9 mmHg — p=>0.05
Bipolar 1 Disorder
Primary: Change From Baseline in Young Mania Rating Scale (Y-MRS) Total Score at Day 21 — -14.4; -14.9; -10.9 Score on a scale — p=0.0136
Acute Coronary Syndrome · Myocardial Infarction · Smoking
Primary: Smoking Abstinence — 32.0; 37.2 percentage of participants
Type 2 Diabetes Mellitus
Primary: Change in HbA1c From Baseline to Month 6 Endpoint — -0.57; -0.56 percentage of hemoglobin
Angina · Pulmonary Arterial Hypertension
Primary: Improve Angina Symptoms — 1.75 units on a scale — p=0.0013
Type 2 Diabetes Mellitus
Primary: Change in HbA1c From Baseline to Month 6 Endpoint — -0.83; -0.83 percentage of hemoglobin
In Vitro Fertilization
Primary: Percentage of Participants With Clinically Relevant Immunogenicity — 0.0; 0.0; 0.0 percentage of participants
Type 2 Diabetes Mellitus
Primary: Change in HbA1c From Baseline to Month 6 Endpoint — -1.42; -1.46 percentage of hemoglobin
Diabetes Type 2
Primary: Change in HbA1c (Glycosylated Hemoglobin) From Baseline to Week 28 — -1.13; -0.75; -0.40 percentage of total hemoglobin — p=0.0010
Painful Diabetic Peripheral Neuropathy
Primary: Average Diabetic Peripheral Neuropathy (DPN) Pain Based on a Numeric Rating Scale (NRS) Over the Last 7 Days of Each Treatment Period (Week 6 of Each Treatment Period)…
Type 1 Diabetes Mellitus
Primary: Change In HbA1c From Baseline to Month 6 Endpoint — -0.40; -0.44 percentage of hemoglobin
Overweight
Primary: Change in Mean Body Weight (kg) — -2.26; -0.56 kg
Facial Wrinkles at the Nasolabial Folds
Primary: Change From Baseline in the Blinded Evaluator's Assessment of Nasolabial Fold (NLF) Wrinkle Severity at Week 24 — 1.8; 1.8 Units on a scale
Diabetes
Primary: Glycated Hemoglobin Levels — 7.88; 7.91; 7.79 Percent — p=0.763